UB Paderborn / Katalog / Suche / in CDI

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

1 – 25 von 1.246

Sortiert nach

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

The New England journal of medicine, 2010-04, Vol.362 (17), p.1563-1574

2010

Volltextzugriff (PDF)

Fibrates for primary prevention of cardiovascular disease events

Cochrane database of systematic reviews, 2016-11, Vol.11 (11), p.CD009753

2016

Volltextzugriff (PDF)

Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration

Molecular pharmaceutics, 2019-05, Vol.16 (5), p.1958-1970

2019

Volltextzugriff (PDF)

Evaluation of a New Formulation of Fenofibric Acid, ABT-335,Co-Administered with Statins: Study Design and Rationale of a Phase III Clinical Programme

Clinical drug investigation, 2008-01, Vol.28 (10), p.625-634

2008

Volltextzugriff (PDF)

Peroxisome Proliferator-Activated Receptors α and γ are Linked with Alcohol Consumption in Mice and Withdrawal and Dependence in Humans

Alcoholism, clinical and experimental research, 2015-01, Vol.39 (1), p.136-145

2015

Volltextzugriff (PDF)

Inhibition of tumor migration and invasion by fenofibrate via suppressing epithelial-mesenchymal transition in breast cancers

Toxicology and applied pharmacology, 2024-02, Vol.483, p.116818-116818, Article 116818

2024

Volltextzugriff (PDF)

Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial

Journal of clinical lipidology, 2018-01, Vol.12 (1), p.173-184

2018

Volltextzugriff (PDF)

Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial

Atherosclerosis, 2016-06, Vol.249, p.36-43

2016

Volltextzugriff (PDF)

Delayed treatment with fenofibrate protects against high-fat diet-induced kidney injury in mice: the possible role of AMPK autophagy

American journal of physiology. Renal physiology, 2017-02, Vol.312 (2), p.F323-F334

2017

Volltextzugriff (PDF)

Targeting DGAT1 inhibits prostate cancer cells growth by inducing autophagy flux blockage via oxidative stress

Oncogene, 2024-01, Vol.43 (2), p.136-150

2024

Volltextzugriff (PDF)

PPAR-α Agonist Fenofibrate Ameliorates Sjögren Syndrome-Like Dacryoadenitis by Modulating Th1/Th17 and Treg Cell Responses in NOD Mice

Investigative ophthalmology & visual science, 2022-06, Vol.63 (6), p.12-12

2022

Volltextzugriff (PDF)

Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events

Cochrane database of systematic reviews, 2018-11, Vol.11 (11), p.CD012502

2018

Volltextzugriff (PDF)

A novel therapy for hepatic cholestasis treatment—the combination of rosiglitazone and fenofibrate

European journal of pharmacology, 2023-01, Vol.938, p.175428-175428, Article 175428

2023

Volltextzugriff (PDF)

Fenofibrate as a COVID-19 modifying drug: Laboratory success versus real-world reality

Atherosclerosis, 2021-12, Vol.339, p.55-56

2021

Volltextzugriff (PDF)

The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study

Ophthalmology (Rochester, Minn.), 2014-12, Vol.121 (12), p.2443

2014

Volltextzugriff (PDF)

Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes

The New England journal of medicine, 2010-07, Vol.363 (3), p.233-244

2010

Volltextzugriff (PDF)

Fenofibrate (PPARalpha agonist) induces beige cell formation in subcutaneous white adipose tissue from diet-induced male obese mice

Molecular and cellular endocrinology, 2015-02, Vol.402, p.86-94

2015

Volltextzugriff (PDF)

Regulation of Monocyte Activation by PPARα Through Interaction With the cGAS-STING Pathway

Diabetes (New York, N.Y.), 2023-07, Vol.72 (7), p.958-972

2023

Volltextzugriff (PDF)

Oral Peroxisome Proliferator-Activated Receptor-α Agonist Enhances Corneal Nerve Regeneration in Patients With Type 2 Diabetes

Diabetes (New York, N.Y.), 2023-07, Vol.72 (7), p.932-946

2023

Volltextzugriff (PDF)

Ternary Eutectic Ezetimibe–Simvastatin–Fenofibrate System and the Physical Stability of Its Amorphous Form

Molecular pharmaceutics, 2021-09, Vol.18 (9), p.3588-3600

2021

Volltextzugriff (PDF)

New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease

Expert opinion on pharmacotherapy, 2014-03, Vol.15 (4), p.493-503

2014

Volltextzugriff (PDF)

Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

Cochrane database of systematic reviews, 2013-12 (12), p.CD008623-CD008623

2013

Volltextzugriff (PDF)

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

The Lancet (British edition), 2005-11, Vol.366 (9500), p.1849-1861

2005

Volltextzugriff (PDF)

Effect of Fenofibrate Therapy on Laser Treatment for Diabetic Retinopathy: A Meta-Analysis of Randomized Controlled Trials

Diabetes care, 2022-01, Vol.45 (1), p.e1-e2

2022

Volltextzugriff (PDF)

Use of fenofibrate for intrahepatic cholestasis of pregnancy

Journal of hepatology, 2023-08, Vol.79 (2), p.e84-e86

2023

Volltextzugriff (PDF)

1 – 25 von 1.246

Suche als RSS-Feed

Aktive Filter

SprachePolnisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.122)
Mit Volltextzugriff
(942)

Publikationsform

Sprache

13 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

n.n

Thema

Fenofibrate - Therapeutic Use
(1.112)
Humans
(1.071)
Science & Technology
(967)
Life Sciences & Biomedicine
(950)
Hypolipidemic Agents - Therapeutic Use
(766)
Male
(708)
Female
(559)
Middle Aged
(518)
Fenofibrate
(513)
Adult
(343)
Biological And Medical Sciences
(330)
Medical Sciences
(325)
Aged
(295)
Fenofibrate - Pharmacology
(259)
Animals
(248)
Cardiovascular System & Cardiology
(235)
Triglycerides - Blood
(232)
Pharmacology & Pharmacy
(220)
Treatment Outcome
(204)
Drug Therapy, Combination
(198)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.246)
Ingenta
(608)
Electronic Journals Library
(534)
Journals@Ovid Full Text
(499)
IngentaConnect Journals
(320)
Elsevier ScienceDirect Journals
(303)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(219)
NUS Single-Journal Subscriptions
(219)
SpringerLink_现刊
(171)
Wiley-Blackwell Journals
(113)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(91)
Wiley Online Library
(82)
Taylor & Francis Journals Auto-Holdings Collection
(58)
Taylor & Francis
(53)
Taylor & Francis Current Content Access
(48)
Oxford Journals
(42)
Oxford Journals 2020 Medicine
(37)
SAGE Journals
(32)
Nexis Uni
(31)
Nature
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...